Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EMF | Ann: EMF NTA 30-07-2025 $1.67888 | 07:54 | 0 | 6 | |||
|
|||||||
EMF | Ann: EMF NTA 29-07-2025 $1.66982 | 30/07/25 | 0 | 43 | |||
|
|||||||
EMF | Ann: EMF NTA 28-07-2025 $1.67543 | 29/07/25 | 0 | 49 | |||
|
|||||||
EMF | Ann: EMF NTA 25-07-2025 $1.67014 | 28/07/25 | 0 | 47 | |||
|
|||||||
EMF | Ann: EMF NTA 24-07-2025 $1.67980 | 25/07/25 | 0 | 68 | |||
|
|||||||
EMF | Ann: EMF NTA 23-07-2025 $1.67809 | 24/07/25 | 0 | 52 | |||
|
|||||||
EMF | Ann: EMF NTA 22-07-2025 $1.68206 | 23/07/25 | 0 | 56 | |||
|
|||||||
EMF | Ann: EMF NTA 21-07-2025 $1.67352 | 22/07/25 | 0 | 65 | |||
|
See All Discussions